SIA
QTTB icon

Schechter Investment Advisors’s Q32 Bio QTTB Stock Holding History

Schechter Investment Advisors’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,655
Closed -$18.1K – 705
2023
Q4 		$18.1K Hold
1,655
– – ﹤0.01% 608
2023
Q3 		$34.8K Hold
1,655
– – ﹤0.01% 584
2023
Q2 		$26.4K Hold
1,655
– – ﹤0.01% 630
2023
Q1 		$30.7K Hold
1,655
– – ﹤0.01% 661
2022
Q4 		$37.5K Hold
1,655
– – ﹤0.01% 813
2022
Q3 		$48K Sell
1,655
-277
-14% -$11.3K ﹤0.01% 920
2022
Q2 		$69K Hold
1,932
– – 0.01% 921
2022
Q1 		$106K Buy
1,932
+277
+17% +$17.2K 0.01% 897
2021
Q4 		$108K Buy
+1,655
New +$161K 0.01% 845

Other funds holding QTTB

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Schechter Investment Advisors's QTTB Position: Q1 2024 in Review

Schechter Investment Advisors sold out of Q32 Bio (QTTB) in Q1 2024, closing a stake of 1,655 shares — an estimated $18.1K sold.

Schechter Investment Advisors first reported a position in QTTB in Q4 2021 and held it in 9 quarters. The position peaked at $108K in Q4 2021. 39 funds tracked by Wall St. Rank hold QTTB as of Q1 2024.

  • Schechter Investment Advisors reported no remaining Q32 Bio position as of Q1 2024 after selling out during the quarter.
  • Schechter Investment Advisors sold 1,655 Q32 Bio shares in Q1 2024, an estimated $18.1K.
  • Schechter Investment Advisors first reported a position in Q32 Bio in Q4 2021 and held it in 9 quarters.
  • Schechter Investment Advisors's Q32 Bio position peaked at $108K in Q4 2021.
  • 39 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2024.

Based on Schechter Investment Advisors's 13F filing for Q1 2024, filed 6 May 2024.